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Abstract
Background: Voltage gated sodium channels Nav1.7 are involved in nociceptor nerve action potentials and are known 
to affect pain sensitivity in clinical genetic disorders.
Aims and Objectives: To study Nav1.7 levels in dental pulpitis pain, an inflammatory condition, and burning mouth 
syndrome (BMS), considered a neuropathic orofacial pain disorder.
Methods: Two groups of patients were recruited for this study. One group consisted of patients with dental pulpitis 
pain (n = 5) and controls (n = 12), and the other patients with BMS (n = 7) and controls (n = 10). BMS patients were 
diagnosed according to the International Association for the Study of Pain criteria; a pain history was collected, 
including the visual analogue scale (VAS). Immunohistochemistry with visual intensity and computer image analysis 
were used to evaluate levels of Nav1.7 in dental pulp tissue samples from the dental pulpitis group, and tongue 
biopsies from the BMS group.
Results: There was a significantly increased visual intensity score for Nav1.7 in nerve fibres in the painful dental pulp 
specimens, compared to controls. Image analysis showed a trend for an increase of the Nav1.7 immunoreactive % area 
in the painful pulp group, but this was not statistically significant. When expressed as a ratio of the neurofilament % 
area, there was a strong trend for an increase of Nav1.7 in the painful pulp group. Nav1.7 immunoreactive fibres were 
seen in abundance in the sub-mucosal layer of tongue biopsies, with no significant difference between BMS and 
controls.
Conclusion: Nav1.7 sodium channel may play a significant role in inflammatory dental pain. Clinical trials with selective 
Nav1.7 channel blockers should prioritise dental pulp pain rather than BMS.
Background
Orofacial pain conditions are common and debilitating.
Few studies have investigated the role of novel key pain
ion channels, such as Nav1.7, in these conditions. Such
studies may lead to the development of more effective
treatments.
Dental pain is the most common symptom of diseased
tooth pulp, often as a result of coronal caries of the tooth
[1]. The mature human dental pulp is densely innervated
with fibres that originate from the trigeminal ganglion
[2]. The normal pulp seems insensitive to exteroceptive
stimuli; however, in pathological states such as pulpitis
(inflammation of the pulp), electrical, thermal, mechani-
cal and chemical stimuli all produce a nociceptive
response [3]. Primary and permanent tooth pulps contain
70-90% C-fibres, and thin myelinated A delta fibres [4].
The majority of nerve fibres terminate in the coronal
region of the pulp, forming a subodontoblast plexus, with
40% terminating in the dentinal tubules close to the
odontoblast processes [5]. Strong correlations have been
reported between the afferent discharge frequency of
human pulp nociceptors and pain levels [6].
Nociceptors within the oral mucosa have also been
implicated in another orofacial pain condition, burning
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Page 2 of 7mouth syndrome (BMS). The International Association
for the Study of Pain (IASP) defines BMS as a distinct
neuropathic orofacial pain condition characterised by
bilateral burning oral mucosal pain, usually affecting the
anterior two thirds of the tongue with a lack of any visible
signs of mucosal pathology, and of more than 6 months
duration [7]. The pain intensity ranges from moderate to
severe throughout the day and may last several years
[8,9]. Initiation can be spontaneous or associated with
systemic factors such as diabetes, nutritional deficiencies,
hormonal changes, psychological disorders as well as
local causes including oral infections, allergies, salivary
gland dysfunction and dental treatment [10].
The underlying mechanisms involved in pain initiation
and conduction in BMS and pulpitis are still not fully
understood, but are likely to involve sodium ion channels.
Voltage gated sodium (Nav) channels are known to play a
key role in elicitation of action potentials in neurons,
including nociceptors [11]. There are 9 sub-types of
sodium (Nav) channels in humans, and changes in their
expression may underlie hypersensitivity in pain states
[12]. A subset of voltage-gated sodium channels that
include Nav1.3, Nav1.7, Nav1.8 and Nav1.9, have been
shown to modulate pain [4,13]. These isoforms display
unique expression patterns within specific tissues [12],
and are up- or down-regulated after injury to the nervous
system [11].
The voltage-gated sodium-channel type IX alpha sub-
unit, known as Nav1.7 and encoded by the gene SCN9A
[14], is located in peripheral neurons and plays an impor-
tant role in the action potential of these cells. Nav1.7 is
concentrated preferentially in rodent small diameter neu-
rons [15]. The presence of Nav1.7 sodium channel has
been demonstrated in sensory neurons in human dorsal
root ganglia (DRG), including the majority of small and
medium-sized neuronal cell bodies, which include the
nociceptors [16]. The accumulation of this channel has
been demonstrated within the neurite tips of DRG and
trigeminal ganglion neurons in culture [17]. Electrophysi-
ological studies show that Nav1.7 has a role in amplifying
generator potentials [18].
The key role of Nav1.7 channels in pain conduction was
confirmed in recent studies of clinical genetic disorders.
Gain-of-function mutations in Nav1.7 have been shown
to cause primary erythermalgia and familial rectal pain,
recently renamed as paroxysmal extreme pain disorder
[13,19], while loss-of-function mutations result in con-
genital insensitivity to pain [14]. Relatively few studies
have evaluated expression of Nav1.7 in acquired clinical
pain states, and even fewer within trigeminal pain states
[2,20-25]. One recent study investigated pain within the
orofacial pain region and showed an increase in Nav1.7
expression in pulpitis [22], while another study showed a
decrease in Nav1.7 in the neuropathic orofacial pain con-
dition trigeminal neuralgia (TN) [26]. The aim of our
study was to investigate whether Nav1.7 has a role in
BMS, considered a neuropathic orofacial pain disorder,
and to compare this with dental pulpitis, an orofacial
inflammatory pain condition.
Methods
Patients scheduled for dental extraction, and those diag-
nosed with burning mouth syndrome (BMS), at Kings
College London Dental Institute, London, were included
in this study. Patients gave informed consent before par-
ticipating in the study, which had approval from the
North East London Ethics Committee. All patients were
recruited sequentially, none of whom were taking any
medication at the time of the study.
Dental pulpitis
Seventeen permanent molar teeth were tested for posi-
tive neural vitality of the dental pulp one hour prior to
extraction, using an electric pulp tester (analytic technol-
ogy constant current at the mid-buccal surface of the
tooth), and with ethyl chloride. The dental patients were
divided into two groups, those with existing pain from
the tooth (painful pulps; n = 5, with a mean age of 40.3
years [range 36-44 years]) and those with no history of or
existing pain (controls; n = 12, with a mean age range of
37.3 years [range 23-51 years]). The gender distribution
of the groups was M: F 1:1. All the dental pain in this
study was attributable to pulpitis due to extensive dental
caries of the molar tooth. Pulpitis was diagnosed by tak-
ing a full pain history and presence of pain on the day of
extraction, vitality testing of the tooth and clinical radiog-
raphy. The mean duration of pain was 2.9 weeks (range
0.5-8.0), and the indication for extraction of the non-
painful teeth was pericoronitis.
All the teeth were removed by standard buccal
approach under local or general anaesthesia. Subsequent
to the extraction process (lasting less than 5 min), the
teeth were sectioned vertically with a water-cooled drill
and the pulp lifted out, and specimens immediately snap-
frozen at -70°C.
Burning mouth syndrome
Patients attending Kings College London Dental Institute
with a diagnosis of burning mouth syndrome (BMS; n =
7) in accordance with the International Association for
the Study of Pain (IASP) criteria [27], and those attending
for wisdom tooth removal under local analgesia (controls;
n = 10), were invited to join this study in accordance with
the North East London Ethics Committee approval
guidelines. Efforts were made to age and sex-match the
BMS patients with controls; however, although the age
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controls. The mean age for the controls and the BMS
patients was 40 years (range 16-79 years; M:F = 6:4) and
62 years (range 48-82 years; M:F = 5:5), respectively. The
average duration of symptoms for the BMS group was
37.6 months. All patients were asked to report the degree
of pain using the visual analogue scale (VAS) scoring sys-
tem from 0 (no pain) to 10 (worst pain imaginable) prior
to a lingual biopsy. The average pain score was 7.07
(range 5-10). All biopsies, including controls, were under-
taken from the same site, on the right or left dorsal lin-
gual mucosa lateral to the midline in the anterior third of
the tongue, since all BMS patients had pain within this
region.
Tongue punch biopsies were taken from BMS patients
(disposable punch 3 × 3 mm Steifel CE 0120, Steifel Labo-
ratories Ltd, Bucks, U.K.) under local anaesthesia. Con-
trol tongue punch biopsies were obtained from patients
undergoing planned wisdom teeth surgery as a result of
previous pericoronitis, which is localised mucosal inflam-
mation around a partially erupted tooth. During recruit-
ment of these control patients, a clinical history,
examination and radiography were used to confirm this
diagnosis. On the day of surgery, all control patients who
attended for wisdom tooth removal were not in any pain
(VAS = 0) as they were between episodes of pericoronitis.
The control tongue biopsy was an additional procedure,
which required no additional local anaesthesia. All
tongue punch biopsies were immediately placed in liquid
nitrogen, and subsequently transferred to -70°C storage
until used for immunohistochemical analysis.
Immunohistochemistry
Frozen specimens were embedded in OCT medium (RA
Lamb, London, UK) and sections of 12 μm thaw-
mounted onto glass slides pre-coated with poly-L-lysine.
Sections were immersion-fixed in fresh 4% paraformalde-
hyde in phosphate buffered saline (PBS) for 30 minutes,
then endogenous peroxidases blocked by incubation with
alcoholic 0.3% hydrogen peroxide for a further 30 min-
utes. Sections were incubated overnight with a monoclo-
nal antibody to the structural neuronal marker
neurofilament (Clone 2F11, Dako, Cambridge, U.K., used
at a final titre of 1:10, 000) and a polyclonal antibody
against Nav1.7 (K241), whose specificity has been
described by us previously [19,21]. Sites of primary anti-
body attachment were revealed using avidin-biotin per-
oxidase method (Vector Elite ABC method, Vectastain,
Novacastra, Newcastle, UK). Preparations were counter-
stained in 1% w/v aqueous neutral red to visualise nuclei
and photographed with an Olympus photomicroscope.
Analysis
A visual observation method of analysis for the evalua-
tion of Nav 1.7 in the subodontoblast plexus and submu-
cosal region of tongue biopsies was adopted. This was in
accordance with previously described methods [28,29]. A
visual grading scale of intensity ranging between 0-3 (0 =
nil, 1 = weak, 2 = moderate and 3 = strong immunoreac-
tivity) was used. The mean values of readings obtained by
two independent observers, each blinded, were used for
final analysis. Computerised image analysis was also per-
formed to quantify Nav 1.7 immunoreactive area in the
subodontoblast plexus of dental pulp, and submucosal
region of tongue biopsies. Images were captured using an
Olympus DP70 camera mounted to an Olympus BX50
microscope and analysed using analySIS (version 5.0).
Positive Nav 1.7 and neurofilaments immunostaining was
highlighted by setting the grey-level detection limits to
threshold and the area of highlighted immunoreactivity
obtained as% area of the field scanned. Five random fields
per tissue section were scanned and the mean value used
in subsequent statistical analysis. The Mann-Whitney
test was used for statistical analysis (P values < 0.05 were
considered statistically significant). The ratio between
Nav 1.7 and neurofilaments in serial tissue sections was
calculated and used to compare the results from the dif-
ferent groups. The Mann Whitney test was used to com-
pare ratios between groups; P values less than 0.05 were
considered significant.
Results
Figure 1 shows the presence of large numbers of nerve
fibres within human tooth pulp that were immunoreac-
tive for neurofilaments (Figure 1b, d). A subset of nerve
fibres was also immunostained with the Nav1.7 antibody
(Figure 1a, c) in both non-painful and painful pulp
groups. There was a significant increase in the visual
intensity score for Nav1.7 in the painful group compared
Figure 1 Immunoreactive nerve fibres in non-painful (left col-
umn) and painful (right column) human tooth pulp sections, 
within the subodontoblastic plexus region. Staining with antibod-
ies to Nav1.7 (Figures 1a and 1c) and neurofilament cocktail (Figures 1b 
and 1d). Magnification × 40.
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trend for an increase of the Nav1.7 immunoreactive area
in the painful group, but this was not statistically signifi-
cant (Figure 3a). There was no difference between the
neurofilament staining in these groups (Figure 3b), and
when the results were expressed as a ratio of the neurofil-
ament% area, there was also a strong trend for an increase
of Nav1.7 in the painful group (Figure 3c).
There was an abundance of Nav1.7 immunoreactive
fibres in the sub-mucosal layer of both control (Figure 4a)
and BMS tongue biopsies (Figure 4b). No significant dif-
ference was observed between BMS and control biopsies
with image analysis (Figure 4c). There was a trend for an
increase in the visual intensity score for Nav1.7 in the
BMS compared to controls, but this was not statistically
significant (Figure 4d).
Discussion
The role of ion channels has been implicated in subtypes
of pain, such as neuropathic and inflammatory pain [11].
Our study aimed to investigate and compare the expres-
sion of Nav1.7 sodium channel within two orofacial pain
disorders, an inflammatory pain condition dental pulpi-
tis, and burning mouth syndrome (BMS), considered a
neuropathic condition.
This study showed a significant increase in the visual
intensity levels of Nav1.7 immunoreactivity within painful
dental pulp, in accord with a previous study by Luo et al.
(2008) [22]. The latter reported an increase within the
axonal bundles [22], and in our study we observed
increases within the subodontoblastic plexus. With over
900 axons known to enter the average human premolar
tooth, less than half of these fibres that innervate the den-
tal pulp (40%) terminate in dentinal tubules, close to the
odontoblast process. The remaining fibres form the subo-
dontoblastic plexus in the coronal aspect of the pulp tis-
sue [2]. Our study has helped to localise the increased
expression of Nav1.7 to the subodontoblastic plexus
within painful pulp. These findings indicate a possible
involvement of Nav1.7 in toothache, and also suggest a
potential role in human inflammatory pain conditions.
The inflammatory mediators within pulp may up-regu-
late the expression of Nav1.7, as may micro-organisms
within the oral cavity by causing inflammation. It is
unlikely that extracting teeth, or taking tongue biopsies,
under local or general anaesthesia will affect Nav channel
expression; the acute effects of anaesthetics would not be
expected to alter Nav channel levels in the short term, as
Nav channels are synthesized in cell bodies and axonally
transport to the nerve terminals where they are inserted
Figure 2 Visual intensity score of Nav1. 7 in tooth pulp (mean ± 





















Figure 3 Image analysis of control and painful tooth pulp using 
antibodies to Nav1.7 (Figure 3a), neurofilament (Figure 3b) and 
expressing the results as a ratio of Nav1.7:NFL (Figure 3c).
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days.
Previous studies have demonstrated the role of other
sodium channel isoforms within painful pulps. Renton et
al. (2005) showed a significant increase in Nav1.8 fibres as
a proportion of neurofilament positive fibres within pain-
ful dental pulp specimens [2]. Wells et al. (2007) reported
a significant increase in the immunoreactivity of Nav1.9
channels in the axons of painful teeth compared to con-
trol teeth with no pain [25]. Padilla et al. (2007) also stud-
ied the expression of Nav1.9, within rat and mouse
trigeminal ganglion nerve endings [24]. Nav1.9 was
expressed in trigeminal ganglion neuronal somata (small
and medium sized), and also along trigeminal afferent
fibres and the terminal branches within lip skin and den-
tal pulp.
The role of sodium channels has further been demon-
strated in other inflammatory pain conditions. Strickland
et al. (2008) investigated the changes in expression of
Nav1.7, Nav1.8 and Nav1.9 sodium channels in the rat
model and showed that the dorsal root ganglia innervat-
ing the knee joint had increased expression of all three
subtypes up to 28 days after the initial insult [30]. Our
previous study demonstrated an increase of sodium
channels Nav1.7, Nav1.8 and Nav1.9 in hypersensitivity
states of nasal mucosa in patients with allergic and non-
allergic rhinitis [21]. These studies support a potential
role of these sodium channels in chronic inflammatory
pain and hypersensitivity [30].
Burning mouth syndrome (BMS) is defined as a distinct
neuropathic orofacial pain condition affecting the oral
mucosa according to the International Association for the
Study of Pain (IASP). The classification of BMS as a neu-
ropathic pain condition is supported by several previous
studies which demonstrate the loss of intra-epithelial
nerve fibres, and evidence of small fibre neuropathic
changes [31,32]. The BMS patients who participated in
this study were recruited in accordance to the Interna-
tional Association for the Study of Pain (IASP) in order to
minimise any heterogeneity [27]. BMS patients reported
moderate to severe pain intensity, which was similar to
previous studies [7,8]. The expression of Nav1.7 sodium
Figure 4 Immunoreactive Nav1.7 nerve fibres in control tongue (Figure 4a) and burning mouth syndrome (Figure 4b), magnification × 40. 
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nificantly in BMS in this study. While efforts were made
to match the BMS patients with controls and the age
ranges overlap, the BMS subjects were older than the
controls, and this needs to be taken into consideration.
Our previous work also did not show a significant change
in another sodium channel isoform Nav1.8 in BMS,
whereas the levels of the heat and capsaicin receptor,
transient receptor potential Vanilloid (TRPV1), were
increased [31].
As we did not observe a significant change in TRPV1
immunoreactivity levels in painful dental pulpitis com-
pared to non-painful tooth pulp [33], there appears to be
differential expression of sodium and TRP channels in
trigeminal pain disorders - further studies are required to
confirm the increase of Nav1.7, Nav1.8 and Nav1.9 in
inflammatory and TRPV1 in neuropathic trigeminal pain
states. A recent investigation in trigeminal neuralgia, a
neuropathic pain condition, demonstrated that Nav1.7
levels were decreased. Nav1.7 thus appears more likely to
be involved in acquired inflammatory pain, rather than
neuropathic pain, in trigeminal disorders [26].
The development of novel Nav1.7 selective blockers
remains a challenge, and a major pharmaceutical goal
[34] - studies such as this may identify suitable patient
cohorts for clinical trials with selective sodium channel
antagonists.
Conclusions
The results of this study suggest that the Nav1.7 sodium
channel may play a role in inflammatory dental pain.
Clinical trials with selective Nav1.7 channel blockers may
prioritise dental pulp pain rather than burning mouth
syndrome.
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